{"name":"Altheos, Inc.","slug":"altheos-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Stage 1 - ATS907 - Dose 1","genericName":"Stage 1 - ATS907 - Dose 1","slug":"stage-1-ats907-dose-1","indication":"Other","status":"phase_1"},{"name":"Timoptic","genericName":"Timoptic","slug":"timoptic","indication":"Other","status":"discontinued"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ATS907","genericName":"ATS907","slug":"ats907","indication":"Moderate to severe atopic dermatitis","status":"phase_2"}]}],"pipeline":[{"name":"ATS907","genericName":"ATS907","slug":"ats907","phase":"phase_2","mechanism":"ATS907 is a small molecule that targets the S1P1 receptor.","indications":["Moderate to severe atopic dermatitis"],"catalyst":""},{"name":"Stage 1 - ATS907 - Dose 1","genericName":"Stage 1 - ATS907 - Dose 1","slug":"stage-1-ats907-dose-1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Timoptic","genericName":"Timoptic","slug":"timoptic","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":1,"phase_1":1,"discontinued":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}